M&A

Pilgrim's Europe's acquisition of Walkers Deli & Sausage is more than a deal; it's a strategic realignment of the UK's food supply chain. What does it mean?

JLL Partners' acquisition of Life Couriers and the appointment of a new CEO signal a major bet on the future of time-critical healthcare logistics.

OceanaGold makes its Australian debut, acquiring Ausgold for A$776M to develop the Katanning Gold Project. A deep dive into the deal's strategic impact.

In a strategic pivot, Skye Bioscience acquires Redx Pharma, creating Fibrx Therapeutics—a new Nasdaq-listed player armed with $125M and a bold plan.

With assets soaring 290% and revenue nearly doubling, PMGC Holdings' pivot to strategic acquisitions in aerospace and tech is paying off spectacularly.

TWFG just secured a $125M credit facility. It's not just about money; it's a strategic move to accelerate acquisitions and pioneer an AI-driven future for insurance.

With mounting losses and a CEO's unyielding optimism, activist investors issue an ultimatum: take proteomics firm Seer private or face the consequences.

With a key hire and a recent acquisition, FMG Leading is building a new advisory arsenal. Can this blend of human expertise and market intelligence win the high-stakes healthcare investment game?

With strong Q2 results as a tailwind, Interlink is making a bold move with a transformative acquisition and new sensor tech. But can it execute?

The DermCare and USDP merger creates a dermatology behemoth. What does this consolidation mean for patients, doctors, and the future of specialized care?

Two firms unite to form Endure, a national platform for critical power. They promise seamless service, but in a world reliant on data, the real test is just beginning.

Q2 data reveals a stark divergence: private markets show steady, earnings-driven growth while public markets chase AI hype. But beneath the surface, a new era of selectivity emerges.

With a blockbuster IPO and dazzling growth, Bending Spoons looks unstoppable. But a closer look reveals a high-stakes strategy built on massive debt.

Radian has bet its future on a massive strategic pivot. New CEO Mike Weinbach brings a mortgage tech playbook to a complex global insurance game. Will it work?

A Hong Kong wet trades firm is buying into a European spa distributor. A bold strategic leap or a risky diversification into an unfamiliar market?

While rivals fret over housing oversupply, Finland's Lumo Homes just made a billion-dollar acquisition. Here's how the move is already fueling record growth.

North American Construction Group posts record Q2 revenue on its Australian bet, but integration costs and Canadian headwinds reveal a complex growth story.

Marchex's standalone revenue is falling, but its major AI acquisition, Archenia, is already boosting its outlook. Can this strategic pivot deliver lasting value?

Genomic pioneer Sangamo sells key assets to PTC and Lilly in a $163M bankruptcy deal, reshaping the future of gene therapy and rare disease treatment.

The private credit firm posted a strong quarter with a rising NAV, but the real story is the recent acquisition of its advisor by asset giant Ridgepost Capital.